Rooted in "Do No Harm," Growing with "User-Centricity"—Letting Every Technology Branch into Warmth

BioRay Biotech's corporate culture has never been empty slogans hanging in the air. It is deeply rooted in the original intention of "seeking Non-Invasive Therapeutics," and through the daily actions of our R&D, medical care, and public welfare teams, we transform "scientific rigor" and "humanistic care" into tangible, touchable value. This is not only BioRay Biotech's core competitive advantage over industry peers but also a key signal to investors and the public of our commitment to "long-term operation and responsible development."

Core Values: Two Principles Safeguarding the Essence of Health

1."Do No Harm (Non-Invasive Therapeutics)": The Bottom Line of All Technologies

From strain R&D to service delivery, "not adding burden to the body" is BioRay Biotech's unwavering commitment:
• R&D: Patented probiotics (such as BRAP-01) undergo triple safety testing; CIK cell therapy uses autologous cells.
• Production: Food manufacturing strictly adheres to ISO 22000 and HACCP throughout, ensuring product safety and quality through scientific, systematic approaches.
• Service: CIK therapy is paired with "patient care specialists" to reduce user anxiety.

Chairman Hsu Ting-Yuan states: "No matter how advanced the technology, it means nothing if it harms the body—BioRay Biotech ensures that health and safety are never an either/or choice."

2."User-Centricity": Technology Born for Better Living

BioRay Biotech's technology never strays from real needs, staying closely attuned to users' authentic pain points:

• Tailored to Taiwanese Physiology: Strains isolated from Taiwanese gut microbiota, with BRAP-01 regulating allergic constitution.
• Convenient Daily Use: Anti-blue-light Cordyceps xanthophyll—"one capsule daily with meals," no fasting required.
• Attention to Vulnerable Groups: "Red-Yellow-Green" labeling system, easily understood by seniors.